CANDEL THERAPEUTICS, INC. Income Taxes Paid
CANDEL THERAPEUTICS, INC. (CADL) reported Income Taxes Paid of $0 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2024-08-13
- CANDEL THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-12-31 was $27.00K, a 2600.00% increase year-over-year.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-09-30 was $23.00K, a 228.57% increase year-over-year.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-06-30 was $48.00K, a 220.00% increase year-over-year.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-03-31 was $85.00K, a 1316.67% increase year-over-year.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for fiscal 2022 was $183.00K, a 531.03% increase from fiscal 2021.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for fiscal 2021 was $29.00K, a 68.82% decline from fiscal 2020.
- CANDEL THERAPEUTICS, INC. income taxes paid, net for fiscal 2020 was $93.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2023-06-30 | $168.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $50.00K derived: sum of 2 quarters · filed 2024-03-28 | $98.00K derived: sum of 3 quarters · filed 2024-03-28 | $183.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $71.00K derived: sum of 2 quarters · filed 2023-11-09 | $156.00K 10-Q · filed 2023-11-09 | $157.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $133.00K 10-Q · filed 2023-08-10 | $134.00K derived: sum of 3 quarters · filed 2023-08-10 | $141.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-11 | $86.00K derived: sum of 2 quarters · filed 2023-05-11 | $93.00K derived: sum of 3 quarters · filed 2023-05-11 | $108.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $8.00K derived: sum of 2 quarters · filed 2023-03-30 | $23.00K derived: sum of 3 quarters · filed 2023-03-30 | $29.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $22.00K derived: sum of 2 quarters · filed 2022-11-10 | $28.00K 10-Q · filed 2022-11-10 | $40.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $21.00K 10-Q · filed 2022-08-05 | $33.00K derived: sum of 3 quarters · filed 2022-08-05 | $95.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-12 | $18.00K derived: sum of 2 quarters · filed 2022-05-12 | $80.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $74.00K derived: sum of 2 quarters · filed 2022-03-29 | $93.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $81.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $19.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |